Posted on December 5th, 2011 by
…A few reports have indicated that Pfizer, the maker of Lipitor, is not quietly yielding to the eventual demise of its multi-billion dollar cash cow...Those sentiments were echoed by Randal J. Thomas, MD, MS, from the Mayo Clinic's Cardiovascular Health Clinic in Rochester, Minn. "One area of possible concern with generic medications is the possibility that the generic atorvastatin options will be different in potency compared to Lipitor brand atorvastatin," he wrote in an email to MedPage Today and ABC News. "This difference is likely to be minimal, but it will be important for patients who switch from brand-name Lipitor to generic atorvastatin to follow up with blood tests and a check-up with the healthcare provider to make sure that the atorvastatin dose is the right one for them.”
MedPage Today, by Chris Kaiser, 11/30/11
Additional coverage: Everyday Health
You must be logged-in to the site to post a comment.